Displaying drugs 7151 - 7175 of 13635 in total
Alvircept sudotox
Alvircept Sudotox has been used in trials studying the treatment of HIV Infections.
Investigational
Matched Description: … Alvircept Sudotox has been used in trials studying the treatment of HIV Infections. …
trans-urocanic acid
Experimental
VOR33
VOR33 is an allogeneic CRISPR/Cas9 genome-edited hematopoietic stem and progenitor cell (HSPC) therapy product lacking the CD33 protein.
Investigational
Tetroxoprim
Experimental
Matched Categories: … Antibacterials for Systemic Use ... Antiinfectives for Systemic Use …
Isocaproic acid
Experimental
3-Phosphono-D-alanine
Experimental
AVS-100
Investigational
Ethanesulfonic acid
Experimental
Udonitrectag
Investigational
Ozekibart
Ozekibart is a tetravalent recombinant humanized IgG1 agonist antibody targeting the human TRAIL death receptor 5 (DR5). It is being investigated for the treatment of chondrosarcoma.
Investigational
Matched Description: … It is being investigated for the treatment of chondrosarcoma. ... Ozekibart is a tetravalent recombinant humanized IgG1 agonist antibody targeting the human TRAIL death …
rGLP-1
rGLP-1 is a continuous infusion of glucagon-like peptide 1, or GLP-1, targeted for the treatment of congestive heart failure (CHF) in patients ineligible for transplant. GLP-1 is a naturally occurring hormone produced in the intestines in response to food intake.
Investigational
Matched Description: … heart failure (CHF) in patients ineligible for transplant. ... GLP-1 is a naturally occurring hormone produced in the intestines in response to food intake. ... rGLP-1 is a continuous infusion of glucagon-like peptide 1, or GLP-1, targeted for the treatment of congestive …
CB-1158
CB-1158 is under investigation in clinical trial NCT03910530 (A Study of INCMGA00012, INCB001158, and the Combination in Japanese Participants With Advanced Solid Tumors).
Investigational
Matched Description: … CB-1158 is under investigation in clinical trial NCT03910530 (A Study of INCMGA00012, INCB001158, and ... the Combination in Japanese Participants With Advanced Solid Tumors). …
VGV-1
VGV-1 is a potential salvage therapy for treatment of HIV infected people who have failed anti-retroviral therapy.
Investigational
Matched Description: … VGV-1 is a potential salvage therapy for treatment of HIV infected people who have failed anti-retroviral …
Alidornase alfa
Investigational
S-Arsonocysteine
Experimental
Asiaticoside
Experimental
L-Arabinose
Investigational
Inetetamab
Inetetamab is a trastuzumab analog. It differs from trastuzumab by a two amino acid variation in its Fc domain (allotype variation), and possesses an exact F(ab’)2 of trastuzumab.
Investigational
Matched Description: … It differs from trastuzumab by a two amino acid variation in its Fc domain (allotype variation), and ... Inetetamab is a trastuzumab analog. …
Iratumumab
Immunoglobulin G1, anti-(human CD30 (antigen)) (human monoclonal MDX-060 heavy chain), disulfide with human monoclonal MDX-060 light chain, dimer. Molecular weight is approximately 170,000 daltons. In phase I/II clinical trials for treatment of CD30+ lymphomas.
Investigational
Matched Description: … In phase I/II clinical trials for treatment of CD30+ lymphomas. …
Simurosertib
Simurosertib is under investigation in clinical trial NCT03261947 (A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors).
Investigational
Matched Description: … Simurosertib is under investigation in clinical trial NCT03261947 (A Study to Evaluate the Safety, Tolerability ... , and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer …
Bis(6-aminohexyl)amine
Experimental
OSI-461
OSI-461 is a second-generation molecule belonging to a new class of drugs termed selective apoptotic anti-neoplastic drugs (SAANDs).
Investigational
Matched Description: … OSI-461 is a second-generation molecule belonging to a new class of drugs termed selective apoptotic …
CGC-11047
CGC-11047 is a polyamine analog designed to halt cell growth and induce apoptosis.
Investigational
Matched Description: … CGC-11047 is a polyamine analog designed to halt cell growth and induce apoptosis. …
Deramciclane
Deramciclane (EGIS-3886) is used for the treatment of a number of anxiety disorders. Deramciclane differs from other anti anxiety medications in that it is not a benzodiazepine and so has a different structure and target. It antagonizes 5-HT2A receptors, agonizes 5-HT2C receptors, and functions as a GABA reuptake inhibitor.
Investigational
Matched Description: … Deramciclane (EGIS-3886) is used for the treatment of a number of anxiety disorders. ... Deramciclane differs from other anti anxiety medications in that it is not a benzodiazepine and so has ... a different structure and target. …
Displaying drugs 7151 - 7175 of 13635 in total